Rogo takes strategic investment from Citi, Barclays, BNP Paribas and Société Générale
Four global banks back the financial AI startup as it pushes its analyst-facing tools past its initial Wall Street footprint.

Four global banks back the financial AI startup as it pushes its analyst-facing tools past its initial Wall Street footprint.

The Lazard-alum-founded workflow AI vendor is now running ahead of Hebbia on disclosed revenue after an April Series D marked it at roughly USD 2B.

Shanghai-based expert network platform will feed qualitative research on Chinese industries into S&P Global Market Intelligence's flagship terminal.

Seoul-based AI search company brings on Korea Development Bank and KB Securities as it pushes into enterprise finance and academic verticals.

The New York-based investment banking AI startup counts Nomura, Daiwa, Barclays' Asia offices and GIC among its regional clients.

The former X head of product is limiting bookings to venture-backed companies, with pricing that sits well above traditional expert-call rates.

The expert-network marketplace attributes roughly 14,500 CDDs to the leading consulting firms, with Bain alone accounting for about 2,300 a year.

Max Friberg's read: PE megafunds running expert calls in-house with Claude pressures the middle of the CDD stack, but the IC rubber stamp and independent perspective still anchor the engagement.

The fundamentals-data vendor is pitching itself as the structured layer beneath ChatGPT, Claude, Perplexity, and Rogo workflows.

Revenue down 6% YoY; Monocl expert-intelligence platform flagged as a bright spot on the call.

The recognition lands as flexible-talent platforms continue eating into work that once defaulted to MBB and Big Four bench teams.

An r/ATYR_Alpha post breaks down a Leerink MEDACorp expert call with two EFZO-FIT investigators ahead of readout.

Two announcements in three days position FactSet's data feed as a direct endpoint for LLM-driven research, ahead of the rest of the financial data stack.

A 670-physician panel from the expert network points to rising LADA recognition, with CGMs and antibody panels carrying the diagnostic load.

The ingredients giant pushes deeper into high-purity stevia as reformulators chase sugar-reduction targets without the aftertaste penalty.
